vs
Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $154.8M, roughly 1.1× Commercial Vehicle Group, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -10.8%).
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CVGI vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $154.8M | $168.4M |
| Net Profit | — | — |
| Gross Margin | 9.7% | — |
| Operating Margin | -1.2% | 50.6% |
| Net Margin | — | — |
| Revenue YoY | -5.2% | 143.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.8M | $168.4M | ||
| Q3 25 | $152.5M | $87.3M | ||
| Q2 25 | $172.0M | $82.4M | ||
| Q1 25 | $169.8M | $65.0M | ||
| Q4 24 | $163.3M | $69.1M | ||
| Q3 24 | $171.8M | $51.6M | ||
| Q2 24 | $193.7M | $73.8M | ||
| Q1 24 | $194.6M | $137.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-7.1M | $-31.3M | ||
| Q2 25 | $-4.8M | $-12.7M | ||
| Q1 25 | $-4.3M | $-40.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.5M | $-29.5M | ||
| Q2 24 | $-1.6M | $-61.9M | ||
| Q1 24 | $2.9M | $61.0M |
| Q4 25 | 9.7% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 11.9% | — |
| Q4 25 | -1.2% | 50.6% | ||
| Q3 25 | -0.7% | -11.4% | ||
| Q2 25 | 0.5% | 8.6% | ||
| Q1 25 | 0.8% | -34.0% | ||
| Q4 24 | -3.2% | -6.4% | ||
| Q3 24 | -0.6% | -31.0% | ||
| Q2 24 | 0.5% | 3.5% | ||
| Q1 24 | 2.3% | 52.5% |
| Q4 25 | — | — | ||
| Q3 25 | -4.6% | -35.9% | ||
| Q2 25 | -2.8% | -15.4% | ||
| Q1 25 | -2.5% | -62.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.5% | -57.2% | ||
| Q2 24 | -0.8% | -83.9% | ||
| Q1 24 | 1.5% | 44.3% |
| Q4 25 | — | $0.32 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | $-0.05 | $-0.33 | ||
| Q1 24 | $0.09 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $167.9M |
| Total DebtLower is stronger | $104.9M | — |
| Stockholders' EquityBook value | $133.4M | $-302.0M |
| Total Assets | $391.7M | $465.9M |
| Debt / EquityLower = less leverage | 0.79× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $167.9M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $86.1M | ||
| Q1 25 | — | $114.6M | ||
| Q4 24 | — | $144.8M | ||
| Q3 24 | — | $144.7M | ||
| Q2 24 | — | $189.3M | ||
| Q1 24 | — | $226.6M |
| Q4 25 | $104.9M | — | ||
| Q3 25 | $108.2M | — | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $117.4M | — | ||
| Q4 24 | $135.5M | — | ||
| Q3 24 | $128.8M | — | ||
| Q2 24 | $142.0M | — | ||
| Q1 24 | $155.7M | — |
| Q4 25 | $133.4M | $-302.0M | ||
| Q3 25 | $136.5M | $-451.4M | ||
| Q2 25 | $142.6M | $-433.5M | ||
| Q1 25 | $136.7M | $-426.2M | ||
| Q4 24 | $135.6M | $-388.7M | ||
| Q3 24 | $179.3M | $-370.2M | ||
| Q2 24 | $169.6M | $-344.2M | ||
| Q1 24 | $175.5M | $-294.3M |
| Q4 25 | $391.7M | $465.9M | ||
| Q3 25 | $400.3M | $364.0M | ||
| Q2 25 | $429.8M | $347.1M | ||
| Q1 25 | $419.8M | $324.0M | ||
| Q4 24 | $424.6M | $343.8M | ||
| Q3 24 | $495.3M | $314.1M | ||
| Q2 24 | $503.2M | $352.3M | ||
| Q1 24 | $509.2M | $373.1M |
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.89× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $45.2M |
| Free Cash FlowOCF − Capex | $8.7M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 2.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $45.2M | ||
| Q3 25 | $-1.7M | $-4.3M | ||
| Q2 25 | $18.9M | $-31.4M | ||
| Q1 25 | $15.2M | $-22.6M | ||
| Q4 24 | $-26.6M | $-35.0M | ||
| Q3 24 | $-17.1M | $-35.3M | ||
| Q2 24 | $12.6M | $-7.2M | ||
| Q1 24 | $-2.4M | $53.8M |
| Q4 25 | $8.7M | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $11.4M | — | ||
| Q4 24 | $-30.6M | — | ||
| Q3 24 | $-20.3M | $-35.5M | ||
| Q2 24 | $6.4M | $-7.3M | ||
| Q1 24 | $-7.4M | $53.8M |
| Q4 25 | 5.6% | — | ||
| Q3 25 | -2.3% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | -18.7% | — | ||
| Q3 24 | -11.8% | -68.7% | ||
| Q2 24 | 3.3% | -9.9% | ||
| Q1 24 | -3.8% | 39.0% |
| Q4 25 | 2.3% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 2.2% | 0.0% | ||
| Q4 24 | 2.4% | 0.0% | ||
| Q3 24 | 1.9% | 0.3% | ||
| Q2 24 | 3.2% | 0.1% | ||
| Q1 24 | 2.6% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.79× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.80× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
